Microbiology	B:C0085672
of	O
the	O
Upper	O
and	O
Lower	O
Airways	I:C0231989
in	O
Pediatric	O
Cystic	O
Fibrosis	I:C0010674
Patients	O
.	O

Microbiology	O
of	O
the	O
Upper	B:C0225377
and	O
Lower	O
Airways	I:C0231989
in	O
Pediatric	O
Cystic	O
Fibrosis	I:C0010674
Patients	O
.	O

Microbiology	O
of	O
the	O
Upper	O
and	O
Lower	B:C0231989
Airways	I:C0231989
in	O
Pediatric	O
Cystic	O
Fibrosis	I:C0010674
Patients	O
.	O

Microbiology	O
of	O
the	O
Upper	O
and	O
Lower	O
Airways	I:C0231989
in	O
Pediatric	O
Cystic	B:C0010674
Fibrosis	I:C0010674
Patients	O
.	O

To	O
evaluate	O
the	O
microbiology	O
of	O
the	O
upper	O
and	O
lower	O
airways	O
in	O
pediatric	O
cystic	B:C0010674
fibrosis	I:C0010674
(	O
cystic	O
fibrosis	I:C0010674
)	O
patients	O
who	O
underwent	O
sinus	O
surgery	I:C0748725
.	O

To	O
evaluate	O
the	O
microbiology	O
of	O
the	O
upper	O
and	O
lower	O
airways	O
in	O
pediatric	O
cystic	O
fibrosis	I:C0010674
(	O
cystic	B:C0010674
fibrosis	I:C0010674
)	O
patients	O
who	O
underwent	O
sinus	O
surgery	I:C0748725
.	O

To	O
evaluate	O
the	O
microbiology	O
of	O
the	O
upper	O
and	O
lower	O
airways	O
in	O
pediatric	O
cystic	O
fibrosis	I:C0010674
(	O
cystic	O
fibrosis	I:C0010674
)	O
patients	O
who	O
underwent	O
sinus	B:C0748725
surgery	I:C0748725
.	O

Study	O
Design	O
Retrospective	B:C0035363
case	O
series	O
with	O
chart	O
review	O
.	O

Setting	O
Tertiary	B:C0337954
care	I:C0337954
children	O
's	I:C0020017
hospital	I:C0020017
.	O

Setting	O
Tertiary	O
care	I:C0337954
children	B:C0020017
's	I:C0020017
hospital	I:C0020017
.	O

Subjects	O
and	O
Methods	O
A	O
total	O
of	O
201	O
paired	O
sinus	O
and	O
pulmonary	O
cultures	O
from	O
105	O
cystic	B:C0010674
fibrosis	I:C0010674
patients	O
were	O
identified	O
between	O
1996	O
and	O
2014	O
.	O

Demographics	B:C0011289
and	O
culture	O
results	O
were	O
analyzed	O
.	O

Demographics	O
and	O
culture	B:C0430400
results	O
were	O
analyzed	O
.	O

The	O
mean	O
age	O
of	O
patients	O
was	O
11.2	O
Â±	O
5.4	O
years	O
(	O
range	O
,	O
1	O
-	O
27	O
years	O
)	O
,	O
and	O
approximately	O
one	O
-	O
half	O
were	O
female	B:C0043210
.	O

Methicillin	B:C0025643
-	O
sensitive	O
Staphylococcus	O
aureus	I:C0038172
was	O
the	O
most	O
common	O
pathogen	O
overall	O
.	O

Methicillin	O
-	O
sensitive	O
Staphylococcus	B:C0038172
aureus	I:C0038172
was	O
the	O
most	O
common	O
pathogen	O
overall	O
.	O

A	O
significantly	O
higher	O
prevalence	O
of	O
Pseudomonas	B:C0033809
aeruginosa	I:C0033809
(	O
32	O
%	O
for	O
pulmonary	O
and	O
37	O
%	O
for	O
sinus	O
cultures	O
)	O
was	O
observed	O
in	O
older	O
patients	O
versus	O
younger	O
patients	O
(	O
P	O
<	O
.001	O
)	O
.	O

A	O
significantly	O
higher	O
prevalence	O
of	O
Pseudomonas	O
aeruginosa	I:C0033809
(	O
32	O
%	O
for	O
pulmonary	O
and	O
37	O
%	O
for	O
sinus	O
cultures	O
)	O
was	O
observed	O
in	O
older	B:C1999167
patients	O
versus	O
younger	O
patients	O
(	O
P	O
<	O
.001	O
)	O
.	O

There	O
was	O
low	O
to	O
moderate	O
agreement	O
between	O
sinus	O
and	O
pulmonary	O
cultures	O
(	O
Kappa	B:C0439099
statistic	O
range	O
,	O
0.03	O
-	O
0.56	O
)	O
.	O

The	O
prevalence	O
of	O
methicillin	B:C1265292
-	I:C1265292
resistant	I:C1265292
S	I:C1265292
aureus	I:C1265292
(	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
S	I:C1265292
aureus	I:C1265292
)	O
increased	O
significantly	O
for	O
lower	O
respiratory	O
tract	O
culture	O
(	O
from	O
5	O
%	O
to	O
16	O
%	O
)	O
and	O
sinus	O
culture	O
(	O
from	O
5	O
%	O
to	O
27	O
%	O
)	O
between	O
1996	O
-	O
2004	O
and	O
2010	O
-	O
2014	O
(	O
P	O
=	O
.016	O
and	O
P	O
<	O
.001	O
,	O
respectively	O
)	O
.	O

The	O
prevalence	O
of	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
S	I:C1265292
aureus	I:C1265292
(	O
methicillin	B:C1265292
-	I:C1265292
resistant	I:C1265292
S	I:C1265292
aureus	I:C1265292
)	O
increased	O
significantly	O
for	O
lower	O
respiratory	O
tract	O
culture	O
(	O
from	O
5	O
%	O
to	O
16	O
%	O
)	O
and	O
sinus	O
culture	O
(	O
from	O
5	O
%	O
to	O
27	O
%	O
)	O
between	O
1996	O
-	O
2004	O
and	O
2010	O
-	O
2014	O
(	O
P	O
=	O
.016	O
and	O
P	O
<	O
.001	O
,	O
respectively	O
)	O
.	O

The	O
prevalence	O
of	O
positive	B:C1514241
sinus	O
cultures	O
increased	O
from	O
40	O
%	O
to	O
85	O
%	O
between	O
1996	O
-	O
2004	O
and	O
2010	O
-	O
2014	O
(	O
P	O
=	O
.018	O
)	O
.	O

Patients	O
with	O
pulmonary	O
methicillin	B:C1265292
-	I:C1265292
resistant	I:C1265292
S	I:C1265292
aureus	I:C1265292
were	O
more	O
likely	O
to	O
be	O
coinfected	O
with	O
pulmonary	O
P	O
aeruginosa	I:C0033809
(	O
risk	O
ratio	O
,	O
2.4	O
;	O
95	O
%	O
CI	O
,	O
1.2-4.8	O
;	O
P	O
=	O
.015	O
)	O
or	O
Aspergillus	O
fumigatus	I:C0004037
(	O
risk	O
ratio	O
,	O
2.2	O
;	O
95	O
%	O
CI	O
,	O
1.2-4.8	O
;	O
P	O
=	O
.035	O
)	O
.	O

Patients	O
with	O
pulmonary	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
S	I:C1265292
aureus	I:C1265292
were	O
more	O
likely	O
to	O
be	O
coinfected	B:C0275524
with	O
pulmonary	O
P	O
aeruginosa	I:C0033809
(	O
risk	O
ratio	O
,	O
2.4	O
;	O
95	O
%	O
CI	O
,	O
1.2-4.8	O
;	O
P	O
=	O
.015	O
)	O
or	O
Aspergillus	O
fumigatus	I:C0004037
(	O
risk	O
ratio	O
,	O
2.2	O
;	O
95	O
%	O
CI	O
,	O
1.2-4.8	O
;	O
P	O
=	O
.035	O
)	O
.	O

Patients	O
with	O
pulmonary	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
S	I:C1265292
aureus	I:C1265292
were	O
more	O
likely	O
to	O
be	O
coinfected	O
with	O
pulmonary	O
P	B:C0033809
aeruginosa	I:C0033809
(	O
risk	O
ratio	O
,	O
2.4	O
;	O
95	O
%	O
CI	O
,	O
1.2-4.8	O
;	O
P	O
=	O
.015	O
)	O
or	O
Aspergillus	O
fumigatus	I:C0004037
(	O
risk	O
ratio	O
,	O
2.2	O
;	O
95	O
%	O
CI	O
,	O
1.2-4.8	O
;	O
P	O
=	O
.035	O
)	O
.	O

Patients	O
with	O
pulmonary	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
S	I:C1265292
aureus	I:C1265292
were	O
more	O
likely	O
to	O
be	O
coinfected	O
with	O
pulmonary	O
P	O
aeruginosa	I:C0033809
(	O
risk	O
ratio	O
,	O
2.4	O
;	O
95	O
%	O
CI	O
,	O
1.2-4.8	O
;	O
P	O
=	O
.015	O
)	O
or	O
Aspergillus	B:C0004037
fumigatus	I:C0004037
(	O
risk	O
ratio	O
,	O
2.2	O
;	O
95	O
%	O
CI	O
,	O
1.2-4.8	O
;	O
P	O
=	O
.035	O
)	O
.	O

There	O
is	O
low	O
to	O
moderate	O
correlation	O
between	O
pulmonary	O
and	O
sinus	B:C0030471
pathogens	O
in	O
cystic	O
fibrosis	I:C0010674
patients	O
.	O

There	O
is	O
low	O
to	O
moderate	O
correlation	O
between	O
pulmonary	O
and	O
sinus	O
pathogens	O
in	O
cystic	B:C0010674
fibrosis	I:C0010674
patients	O
.	O

This	O
is	O
important	O
to	O
consider	O
when	O
treating	B:C0087111
infections	O
.	O

This	O
is	O
important	O
to	O
consider	O
when	O
treating	O
infections	B:C3714514
.	O

The	O
prevalence	O
of	O
methicillin	B:C1265292
-	I:C1265292
resistant	I:C1265292
S	I:C1265292
aureus	I:C1265292
in	O
sinus	O
cultures	O
has	O
increased	O
over	O
time	O
and	O
warrants	O
further	O
investigation	O
.	O

The	O
prevalence	O
of	O
methicillin	O
-	I:C1265292
resistant	I:C1265292
S	I:C1265292
aureus	I:C1265292
in	O
sinus	O
cultures	O
has	O
increased	O
over	O
time	O
and	O
warrants	O
further	O
investigation	B:C0220825
.	O

